A phase I study evaluating COM701 monotherapy and in combination with nivolumab in patients with advanced solid malignancies.

Authors

Ryan Sullivan

Ryan J. Sullivan

Massachusetts General Hospital, Boston, MA

Ryan J. Sullivan, Emerson A. Lim, Manish Sharma, Dale Randall Shepard, Amita Patnaik, Erika Paige Hamilton, Gini F. Fleming, Kyriakos P. Papadopoulos, Adam ElNaggar, Adeboye H. Adewoye, John Hunter, Ecaterina Elena Ileana Dumbrava, Bartosz Chmielowski, Drew W. Rasco, Daniel A. Vaena

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A

Track

Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies

Sub Track

Immune Checkpoints and Stimulatory Receptors

Clinical Trial Registration Number

NCT03667716

Citation

J Clin Oncol 38, 2020 (suppl 5; abstr TPS23)

Abstract #

TPS23

Poster Bd #

D8

Abstract Disclosures

Similar Posters

Poster

2019 ASCO Annual Meeting

A phase I study evaluating COM701 in patients with advanced solid tumors.

A phase I study evaluating COM701 in patients with advanced solid tumors.

First Author: Drew W. Rasco

Poster

2019 ASCO-SITC Clinical Immuno-Oncology Symposium

A phase I study evaluating COM701 in patients with advanced solid tumors.

A phase I study evaluating COM701 in patients with advanced solid tumors.

First Author: Drew W. Rasco

First Author: Wang Yk

First Author: Jermaine Coward